Australian Pharmacist

The popular weight-loss drug Wegovy has been approved to treat cardiovascular disease in patients who are overweight or obese.

In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.

Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.

Pharmacists are asked to lead the shift from reliever to inhaled corticosteroid regimens and to minimise use of oral corticosteroids.

How pharmacists can support patients in the end-of-life period.

This week pharmacists will see a suite of regulatory and funding changes take effect. Here are the six key updates pharmacists need to know before...